CTIC(Delisted)
CTI BioPharmaยทNASDAQ
--
--(--)
CTIC Profile
Cti Biopharma Corp
A biopharmaceutical company that developing novel targeted therapies for blood-related cancers
3101 Western Avenue, Suite 800, Seattle, WA
--
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development and commercialization of methods to reduce toxicity and treat cancer more effectively. The company's goal is to generate revenue through the products it develops, and to build a profitable company alone or with one or more potential partners. At present, they are mainly focused on the treatment of blood-related cancers with huge medical needs. The first and foremost is to commercialize PIXUVRI in Europe. Provides a Phase 3 clinical trial for the treatment of highly relapsed, refractory, moderately and highly malignant non-Hodgkin's lymphoma and myelofibrosis. The company was founded in Washington in 1991.
